U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality
Powered by the Evidence-based Practice Centers
✓ Evidence Reports ✓ All of EHC
✓ Evidence Reports ✓ All of EHC

SHARE:

FacebookTwitterFacebookPrintShare

Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease

Research Report Jan 24, 2012

Findings from this study were published in the following journal articles.

  1. Brookhart MA, Freburger JK, Ellis AR, et al. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 June 20 [Epub ahead of print]. DOI: 10.1681/ASN.2012121164.
  2. Kshirsagar AV, Freburger JK, Ellis AR, et al. The Comparative Short-term Effectiveness of Iron Dosing and Formulations in US Hemodialysis Patients. Am J Med. 2013 Jun;126(6):541.e1-541.e14. PMID: 23597800.

Project Timeline

Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease

Jan 24, 2012
Topic Initiated
Jan 24, 2012
Research Report
Page last reviewed November 2017
Page originally created November 2017

Internet Citation: Research Report: Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease. Content last reviewed November 2017. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
https://effectivehealthcare.ahrq.gov/products/renal-disease-iron/abstract

Select to copy citation